Medication-Related Kidney Injury
Pathophysiology
- NSAIDs cause acute kidney injury primarily through inhibition of renal prostaglandin production, leading to afferent arteriole constriction, decreased renal blood flow, and reduced glomerular filtration rate (GFR) in patients with pre-existing kidney disease, advanced age, volume depletion, diabetes, and heart failure 1, 2
- NSAIDs inhibit cyclooxygenase (COX) enzymes, particularly COX-2, which is crucial for renal prostaglandin production, and this inhibition can precipitate acute kidney injury in high-risk patients 1
Patient Management
- The American Academy of Family Physicians recommends avoiding NSAIDs in high-risk patients and monitoring renal function after initiation in at-risk patients, such as those with pre-existing kidney disease (GFR <60 mL/min/1.73m²), advanced age, volume depletion, diabetes, and heart failure 1
- The European Society for Medical Oncology (ESMO) and the American Journal of Kidney Diseases identify traditional NSAIDs like diclofenac as causes of significant nephrotoxicity, and recommend using losartan, an ARB, with caution, especially in patients with GFR < 60 ml/min/1.73 m² who have serious intercurrent illness 3, 4, 5
- Patients with pre-existing kidney disease, advanced age, volume depletion, diabetes, and heart failure are at increased risk of kidney injury, and the combination of renin-angiotensin system inhibitors, diuretics, and NSAIDs should be avoided, as recommended by the American Society of Nephrology 6, 2, 7
Medication Recommendations
| Medication | Recommendation |
|---|---|
| NSAIDs | Use with caution, maximum daily doses: Ibuprofen 2400 mg/day, Naproxen 1000 mg/day, Diclofenac 150 mg/day, and avoid in high-risk patients [8] |
| Metformin | Continue if GFR ≥45 ml/min/1.73 m², review if GFR 30-44 ml/min/1.73 m², discontinue if GFR <30 ml/min/1.73 m², as recommended by the American Diabetes Association [9, 10] |
| Morphine, meperidine, and codeine | Avoid in patients with renal insufficiency (GFR <30 ml/min/1.73 m²) due to active metabolites and accumulation, and consider alternative opioids like fentanyl, sufentanil, and methadone [11] |
| Lithium | Requires close monitoring of drug levels and renal function, especially in patients with pre-existing kidney disease [9] |
| Digoxin | Requires dose adjustment and careful monitoring, especially in patients with renal insufficiency (GFR <30 ml/min/1.73 m²) [9] |
| Herbal remedies | Avoid in people with chronic kidney disease (CKD), as recommended by the Kidney International guidelines [9] |
| Gadolinium-based contrast media | Avoid in people with GFR <15 ml/min/1.73 m², and consider alternative contrast agents or procedures, as recommended by the Kidney International guidelines [9] |
Analgesic Use
- Acetaminophen is recommended as the preferred first-line analgesic for headache management in patients with renal concerns, with a maximum daily dose of 4000 mg, according to the American College of Physicians and the National Institute of Diabetes and Digestive and Kidney Diseases 8
- The National Institute of Diabetes and Digestive and Kidney Diseases recommends the following analgesic use based on renal function:
Prevention and Monitoring
- Regular monitoring of renal function (serum creatinine, BUN, electrolytes) is essential, especially in patients with GFR <30 mL/min/1.73m², as recommended by the American Diabetes Association and the Kidney International guidelines 6, 7, 9
- Avoiding concurrent use of multiple nephrotoxic agents, using the lowest effective dose for the shortest duration, ensuring adequate hydration, and temporarily discontinuing nephrotoxic medications during acute illness can help prevent kidney injury, as recommended by the American Society of Nephrology and the Kidney International guidelines 6, 7, 9
- Daily monitoring of volume status, blood pressure, and electrolytes, especially potassium, is crucial in patients with AKI, and regular monitoring of renal function is recommended, including checking serum creatinine, BUN, and electrolytes at least every 3 months, or more frequently if GFR <30 ml/min/1.73m², as recommended by the American Journal of Kidney Diseases and the Kidney International guidelines 7, 5
Non-Pharmacological Interventions
- The American Headache Society recommends the following non-pharmacological interventions for headache management: biofeedback, relaxation techniques, acupuncture, cognitive behavioral therapy, trigger avoidance, and adequate hydration, especially in patients with renal concerns 8
- Patients should seek medical or pharmacist advice before using over-the-counter (OTC) medicines or nutritional supplements, as recommended by the Kidney International guidelines, to minimize the risk of kidney injury 9
- All patients with GFR <60 ml/min/1.73 m² undergoing procedures with iodinated contrast should receive appropriate prophylaxis, according to the Kidney International guidelines, to prevent contrast-induced nephropathy 9